メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Skin Safety and Clinical Evaluation of 0.1% Hydrocortisone 17-butyrate 21-propionate (HBP)

研究成果: ジャーナルへの寄稿学術論文査読

抄録

We studied about the skin safety and clinical evaluation of 0.1% Hydrocortisone 17-butyrate 21 -propionate (HBP). 40 patients with skin diseases were patch tested with HBP ointment, cream, ointment base and cream base. And skin irritation indices were calicurated as 2. 5, 1. 25, 1. 75 and 1. 84 respectively. 2 patients were reacted to methyl paraben formulated in the crem base as a preservative. 41 patients with skin diseases were treated with HBP ointment. The patients applied HBP ointment simply to their lesions three times a day. 14 cases out of the 41 patients (34. 2%) were completely cured and 19 cases (46. were well improved within three weeks. Side effect was shown in one case.

本文言語英語
ページ(範囲)130-138
ページ数9
ジャーナル[Hifu] Skin research
26
1
DOI
出版ステータス出版済み - 1984
外部発表はい

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

All Science Journal Classification (ASJC) codes

  • 皮膚病学
  • 感染症

フィンガープリント

「Skin Safety and Clinical Evaluation of 0.1% Hydrocortisone 17-butyrate 21-propionate (HBP)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル